BLOG

Tuesday, November 9, 2021

Safety concerns raised for neuroblastoma candidate drug

Scientists have identified the primary target of the experimental cancer drug CX-5164, revealing a possible risk for late effects of treatment.

from Top Health News -- ScienceDaily https://ift.tt/3bYpQjg
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Omicron has cast a shadow of uncertainty on growth outlook: IndiGo CEO

However, the airline is stronger now when compared to situation in 2020 during the first wave of the pandemic, says Ronojoy Dutta from Com...